Cargando…

Advances in Anti-IgE Therapy

Omalizumab depletes free IgE in the blood and interstitial space and inhibits IgE binding to FcεRI on basophils, mast cells, and dendritic cells. We stopped omalizumab treatment after four years. Recurrences of urticaria symptoms were found to be higher in patients with chronic urticaria than recurr...

Descripción completa

Detalles Bibliográficos
Autor principal: Yalcin, Arzu Didem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4436440/
https://www.ncbi.nlm.nih.gov/pubmed/26075226
http://dx.doi.org/10.1155/2015/317465